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Monitoring and understanding the in vitro behaviour of polyester based scaffolds both comprising 
the study of the hydrolytic degradation and the cell seeding viability is essential to ensure the 
desired functionality, according to a given biomedical purpose. As a model case to compare the 
performance of techniques to monitor the in vitro behaviour, poly(lactide-co-glycolide) (PLGA) 
scaffolds were chosen. 
The in vitro hydrolytic degradation of PLGA scaffolds was carried out in water and phosphate 
buffered saline (PBS). The evolution of the mass loss, the molar mass, the thermal properties and 
the surface morphology were monitored. The hydrolytic degradation media was correspondingly 
evaluated by means of the study of the pH, the amount of acid released and the conductivity.  
In addition, the in vitro biocompatibility regarding the cell culture viability was studied under 
physiological conditions. The cellular adhesion, cellular ability to proliferate on the scaffold, the 
scaffold inflammatory profile and the effect of the scaffold degradation compounds on the cells 
were assessed. 
A comparative analysis of the exploited techniques in terms of promptness of identification, depth 
of knowledge, simplicity of obtaining results and cost of the technique was implemented. The 
results showed that, depending on the balance between the interest in ascertaining the trigger of 
degradation or deep into the knowledge of the causes and effects of cell culture viability, an 
appropriate plan of analysis of the validation of polyester-based scaffolds could be designed. 
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1. Introduction 
Polyesters are one of the most used polymeric materials for biomedical applications such as 
sutures, implants, artificial skin and controlled drug release devices [1]–[4]. Such is the case of 
the poly(lactide) (PLA), poly(glycolide) (PGA), poly(ε-caprolactone) (PCL) or poly(lactide-co-
glycolide) (PLGA) [5]–[9]. The irruption of electrospinning in tissue engineering has boosted the 
technology of production of biomaterials comprising fibrous architectures which diameters can 
vary from several tens to hundreds of nanometres, mimicking the native extracellular matrix and 
allowing enough porosity to facilitate cellular growth [10]–[12]. Precisely, the tuning of these 
scaffolds is required to ensure a balance between enough time of structural endurance to permit 
angiogenesis, and appropriate degradation profiles to be decomposed without delivery of toxic 
low molar mass compounds [13]. In this sense, the development of protocols to establish the 
structure-to-performance relationship of biomedical scaffolds still represents a matter of interest. 
The use of poly(lactide-co-glycolide) (PLGA) as biopolymeric scaffold is well-extended due to 
its equilibrium of performance of durability and bioassimilation trends [14], [15], and therefore 
was taken as model polyester in this work. An equilibrated water‒affinity with reasonable 
degradation times has been found for 50:50 PLGA where the methyl side‒groups of the PLA 
macrosegments confer hydrophobicity to the copolymer [16]. The mechanism of degradation of 
PLGA under abiotic aqueous environments takes place through hydrolysis of the ester bonds, 
auto-catalysed by carboxylic groups, exponentially increasing along the exposure time [17]. 
These microstructural changes induce the formation of macroscopic pores or cracks, and the loss 
of monomeric and oligomeric species, thus reducing the mass of the polymers and finally 
decomposing their architecture until bioassimilation or excretion [18]. PLGA permits different 
preparations and designs. For instance, Farahani et al. studied 50:50 PLGA as compressed discs 
for implants [19], Vey et al. assessed the degradation of cast films [20] and Wu et al. the 
biodegradation of PLGA rods with different compositions [21]. As electrospun scaffolds, some 
characterisation studies of the in vitro degradation have been reported [7], [22]–[28], generally 
considering the monitoring of mass-loss and molar mass along hydrolytic exposure. 
Depending on the area of application and the purpose of the analysis, the focus on the research 
can vary from the deepest knowledge of the degradation mechanisms from the material science 
point of view [29]–[32], to a fast reference trial of materials to identify the relative times of 
decomposition and thus further infer the response under biological conditions in medical studies 
[7], [24], [33], [34]. Therefore, the aim of this work was to compare the suitability of the set of 
analytical techniques schematised in Figure 1 to validate the in vitro behaviour of a model 
electrospun polyester (PLGA) through the study of its hydrolytic degradation and 
biocompatibility. For this purpose, the hydrolytic degradation profiles were monitored in ultra-
pure water and phosphate buffer solution (PBS) at 37 ºC. The scaffold was characterised by 
gravimetric analysis, size exclusion chromatography (SEC), differential scanning calorimetry 
(DSC) and field emission scanning electron microscopy (FE-SEM) while the degradation media 
was monitored by pH measurement, titration of released acids and conductometry. 
Biocompatibility was studied in terms of cellular adhesion, morphology and proliferation of cells, 
the inflammatory profile, and the effect of the scaffold degradation compounds on the cell 
viability were assessed by means of immunofluorescence, FE-SEM, methyl tetrazolium (MTT) 
and pyrogenic assays, respectively. Aspects such as promptness of identification, depth of 
knowledge, simplicity of obtaining results and cost of the techniques were taken into account as 
a basis for specialists to set up an appropriate plan of analysis of the degradation and durability 
of polyester-based scaffolds. 
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Figure 1. Scheme of the in vitro validation techniques used in this study along with the most 
representative indicators for each technique. 
2. Materials and methods 
2.1. Materials 
The 50:50 DL-PLGA used in this study was provided by Lactel Absorbable Polymers 
(Birmingham, USA). Dimethylformamide (DMF) was used as solvent for electrospinning. For 
the hydrolytic degradation procedure, ultra-pure water of type 1 (ISO 3696) [35], Dulbecco’s 
Phosphate Buffered Saline solution (PBS, D1408) and NaOH 1M for adjusting pH in PBS, were 
used. All these reactants, except water, were supplied by Sigma-Aldrich (San Luis, USA) and 
were used without further purification. For the in vitro biocompatibility tests paraformaldehyde 
(PFA) from VWR Chemicals and 4’,6-diamidino-2-phenylindole (DAPI) from Sigma-Aldrich 
were used. 
2.2. Scaffold preparation 
The PLGA scaffolds were obtained by means of an Yflow Electrospinner 2.2.D-350 (Málaga, 
Spain). It consisted in double polarization, integrated drum collector control panel and robotized 
stage to move the electrospinning source in an alternative fashion covering a 400×400 mm2 area. 
PLGA solution was prepared at a 30% by weight in pure DMF under gentle stirring overnight at 
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room temperature. The polymer solution was electrospun at a 14 kV voltage, with a tip-to-
collector distance of 20 cm and a solution flow rate of 1 ml·h-1. The solution jet emerging from 
the stainless steel wire (0.9 mm inner diameter) used as the positive electrode, was collected on a 
waxed paper. Scaffolds, with an average thickness of 1.35×10-2 mm, were obtained and dried over 
12 h under vacuum to facilitate the removal of residual solvent and moisture. 
2.3. In vitro degradation 
The PLGA scaffolds were subjected to hydrolytic degradation under ultra-pure water and 
phosphate buffer saline solution (PBS), according to the international norm ISO 10993-13:2010, 
method 4.3 [36]. Shortly, the initial electrospun scaffolds were cut into rectangular specimens 
with a mass around 10 mg. The specimens were weighed (m0) and placed in a previous weighed 
vial (mvial). 10 ml of degradation medium were introduced, then the vials were sealed with 
polytetrafluoroethylene (PTFE) threaded plugs and placed in a thermostatically controlled oven 
at 37 ºC. The pH of the PBS solution was adjusted to 7.4 with NaOH 1 M. Twelve extractions 
were considered along the hydrolytic degradation over 150 days. In order to monitor the process, 
after certain periods of time, samples were withdrawn from the environment by triplicate. Solid 
and liquid fractions were separated. The liquid fraction was analysed immediately after extraction, 
while the solid fraction followed a washing-drying-keeping procedure before further analysis. 
Actually, those specimens coming from the saline buffer were washed with deionized water and 
then, along with specimens coming from water environment, were dried under vacuum to constant 
mass into their degradation vials (mdry) and saved for further analysis. 
2.4. Scaffold characterisation 
2.4.1. Mass loss monitoring 




× 100 (Equation 3) 
where m0, mvial are the initial mass of the specimen, and the vial, respectively; and mdry, the mass 
of the vacuum dry assembly sample-vial after degradation. 
2.4.2. Size exclusion chromatography (SEC) 
Size exclusion chromatography (SEC) analyses were carried out by means of an Agilent Infinity 
1260 chromatograph. Separation was performed with a Jordi Associates mixed bed fluorinated 
column (permeation range: 100 - 10×106 Dalton). All the samples were dissolved in mobile phase 
of hexafluoroisopropanol (HFIP) containing 2.72 g·L-1of sodium trifluoroacetate (NaTFA). This 
solvent was previously degassed by vacuum filtration over PTFE 0.45 µm pore membranes. Flow 
rate was set at 1 ml·min-1 and 100 µL samples of about 0.1% concentration were injected. 
Detection was conducted by UV-vis-detector. Monodisperse PMMA samples from Sigma-
Aldrich and Agilent were used for previous calibration. The specimens were characterised in 
triplicates and the averages were taken as representative values. 
2.4.3. Fourier transformed infrared spectroscopy (FT-IR) 
The assurance of the composition of the scaffolds was determined via attenuated total reflectance 
(ATR) in a Thermo Nicolet 5700 Fourier transform infrared spectrometer (FT-IR). The average 
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spectra were collected from 64 accumulations with a resolution of 4 cm-1 in the 4000-400 cm-1 
range, from eight different locations of the same specimen. 
2.4.4. Differential scanning calorimetry (DSC) 
Calorimetric data were obtained by differential scanning calorimetry (DSC) with a Mettler-
Toledo DSC 820 series. The DSC equipment was calibrated following the procedure of In and Zn 
standards. The samples, with a mass of about 4 mg were analysed between ‒20 and 220 ºC with 
a heating rate of 10 °C·min-1. All experiments were run under nitrogen atmosphere (50 ml·min-
1). The specimens were characterised at least in triplicates and the averages of temperatures were 
taken as representative values. 
2.4.5. Field emission scanning electron microscopy (FE-SEM) 
The surface morphology of specimens was analysed by means of a Zeiss Ultra 55 field emission 
scanning electron microscope (FE-SEM). The samples were cut into small pieces and dried at 50 
ºC in a vacuum oven for 24 h and then kept in a desiccator during 48 h. Afterwards, the specimens 
were mounted on metal studs and sputter-coated with a platinum layer during 10 s using a Leica 
EM MED020. Testing was performed at room temperature with a 3kV voltage. The fibre 
diameters were measured from the FE-SEM micrographs at random locations (n=100) with the 
aid of Image J software. 
2.5. Characterisation of the degradation media 
2.5.1. pH and conductivity measurements 
The pH and conductivity of the degradation media were measured at room temperature by means 
of Crison pH25 and Crison CM35 devices. Three buffer solutions from Crison were used to 
calibrate the pH-meter: pH 4.01 (phthalate buffer solution), pH 7.00 (phosphate buffer solution), 
pH 10.01 (borate buffer solution). Different KCl solutions (0.1 M, 0.01 M and 0.001 M) with 
conductivities of 12.88 mS·cm-1, 1413 µS·cm-1 and 147 µS·cm-1, respectively, were used to 
calibrate the conductometer. Measurements were carried out in three different specimens per 
sample and the averages were taken as representative values. 
2.5.2. Titration 
The amount of released acid was estimated by means of a titration of the degradation medium. In 
this method, only monomeric units of lactic and glycolic acids are supposed to be released 
according to the methodology proposed by Vey et al. [20]. Aqueous solutions of lactic and 
glycolic acids were prepared at 0.01 M in order to establish an additive pattern curve which related 
the concentration of each compound with the pH. 
2.6. In vitro biocompatibility 
2.6.1. Cell culture 
Human fibroblasts were cultured in high-glucose Dulbecco’s Modified Eagle’s Medium (Sigma-
Aldrich) supplemented with 10% of foetal bovine serum (FBS), penicillin (100 U·ml-1) and 
streptomycin (100 µg·ml-1) (Gibco). Human keratinocytes were cultured in low-glucose 
Dulbecco’s Modified Eagle’s Medium (Sigma-Aldrich) supplemented with 10% of chelated FBS, 
penicillin (100 U·ml-1) and streptomycin (100 µg·ml-1). Cells were harvested for passaging with 
trypsin-EDTA (0.25% trypsin and 0.02% EDTA) solution. 
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2.6.2. Cell-adhesion assay 
In order to evaluate the cell attachment to the scaffolds, 40000 cells were plated onto 1 cm2 of the 
polymer sheet in triplicates. Cells were allowed to attach for 30 min and then cultured in the 
appropriate medium for 48 and 96 h. Thereafter, scaffolds were washed with cold PBS and fixed 
for 20 min with 2% PFA at room temperature, then washed again and finally stained with 4′,6-
diamidino-2-phenylindole (DAPI) for 10 min at RT. Images were acquired in a fluorescence 
microscope. 
As well, to better characterize the cell attachment and morphology, scanning electron microscope 
images were acquired. Briefly, 40000 cells·cm-2 were seeded onto the scaffold and cultured for 
48 h. Then, the cells were foxed with 3% glutaraldehyde solution during 60 min at 37 ºC and 
subsequently critical point dried (CPD). This procedure removes liquids from the specimen and 
avoids surface tension effects, by never allowing a liquid/gas interface to develop [37]. The CPD 
protocol considered was dehydration through a graded series of ethanol (10%, 20%, 30%, 50% 
and 70%, once for 10 min at each step), and then immersed in 100% ethanol twice for 30 min 
each. The tissues were then transferred to a Quorum Technologies Polaron E3000 critical point 
dryer, using liquefied carbon dioxide as transitional fluid. Finally, samples were sputter-coated 
and analysed according to the protocol described in section 2.4.5. 
2.6.3. MTT assay 
Human fibroblasts were plated at a density of 40000 cell·cm-2 onto scaffolds. Proliferation was 
measured in triplicates after 48 and 96 h using thiazolyl blue tetrazolium bromide (MTT assay; 
Sigma-Aldrich), following the manufacturer's instructions. Absorbance was measured at 550 nm 
using a plate reader Halo Led 96 (Dynamica Scientific Ltd.). 
To evaluate the toxicity of the compounds obtained from the scaffold degradation (PLGA), 
different concentrations of lactic and glycolic acid were tested (mM): 0, 10, 20, 30, 40, 50 and 
60.  Fibroblast and keratinocytes were seeded (10000 cells per well of a 96 well plate) and 
incubated during 24 h with the determined concentrations. 
2.6.4. Pyrogen test  
Blood was obtained from the Valencian Blood Tissue Bank after informed consent and was 
processed as described previously [33]. Briefly, peripheral blood mononuclear cells (PBMCs) 
were isolated by Ficoll density gradient centrifugation and incubated in triplicates with the PLGA 
scaffolds during 5 h at a density of 6×106 cells·ml-1. RNA was obtained using QIAzol Lysis 
Reagent and purification was carried out with RNeasy Plus Mini Kit (Qiagen). RNA was 
quantified by spectrometry using a NanoDrop ND-2000 (NanoDrop Technologies). The same 
procedure was used with PBMCs incubated with poly(3-hydroxybutyrate) (PHB) scaffolds. 
2.6.5. Reverse transcription and real-time polymerase chain reaction (RT-PCR) 
cDNA was synthesized from 1 μg of total purified RNA using the High-Capacity cDNA Reverse 
Transcription kit (Applied Biosystems). Primers were designed [33] and RT-PCR was performed 
as previously described [38]. The following pro-inflammatory cytokines were analyzed: IL-1β, 
IL-6, IL-10 and TNF-α, the gene expression levels were normalized to the human housekeeping 
ACTB. Data are represented as the average from triplicate samples. 
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2.6.6 Statistical Analysis 
The results in this study are expressed as mean ± standard deviation (SD). In the biocompatibility 
assays, comparison between experimental conditions were performed with Mann-Whitney test. 
Differences were considered statistically significant at P<0.05 with a 95% confidence interval. 
Analyses were conducted with GraphPad Prism 5 software.  
3. Results and discussion 
3.1. Initial characterisation of the scaffold 
The validation of a given scaffold for tissue engineering starts from an initial or preliminary 
characterisation of this device. Accordingly, it is essential to evaluate some fundamental features 
such as the surface morphology, the fibre diameter, the porosity, the chemical composition and 
the molar mass. These are key factors that will determine the behaviour of the scaffold during 
application. 
Figure 2 shows a FE-SEM image of the surface morphology, along with the histogram of 
diameters of the electrospun PLGA scaffolds. For satisfactory cell attachment and proliferation, 
the fibre diameter (d) must remain in the nanoscale range which is crucial and necessary to mimic 
the extracellular matrix (ECM) size [39]. For the case of PLGA scaffolds, a uniform non-woven 
nanofibrous structure was observed. 
The estimated porosity (Ø) of the scaffold was calculated by means of the Equation 4, 
∅ (%) = (1 −
𝜌
𝜌0
) × 100 (Equation 4) 
where ρ is the density of electrospun sheet considering a thickness of 1.35·10-3 cm and a density 
(ρ0) of 1.25 g·cm-3 for the bulk PLGA [25]. As well, the surface density (ρs), referred to the mass 
per unit area, was calculated by weighing a piece of the scaffold and normalised to the selected 
area. 
 
Figure 2. FE-SEM image (3kV, 1000x, 10 µm) and fibre diameter histogram of PLGA nanofibrous 
scaffold. 
The chemical composition of the scaffold was assessed by means of infrared spectroscopy (FTIR). 
The typical infrared spectra of a given polyester shows the characteristic bands corresponding to 
specific functional groups in the polymer structure. The spectra of the PLGA shows two different 
characteristic bands corresponding to each one of the monomers. The first band located at 1452 
cm-1 corresponds to the asymmetric bending of ‒CH3 from the lactic units and the second one is 
located at 1422 cm-1 and corresponds to the bending of ‒CH2‒ from the glycolic units of the 
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copolymer. Thus, the relative quantity of lactic and glycolic units could be estimated by the 








  (Equation 6) 
where I1452 and I1422 are the intensities of the bands at 1452 cm-1 and 1422 cm-1, respectively. The 
scaffold composition was revealed to be close to 1:1 ratio of glycolic-lactic units (56:44). 
The molar mass analysis was performed by means of size exclusion chromatography (SEC) in 
terms of number average molar mass (Mn) and weight average molar mass (Mw). Result showed 
values around 45 000 g·mol-1 for Mn and 87 000 g·mol-1 for Mw. 
Table 1. Porosity, fibre diameter, composition and average molar masses of initial PLGA scaffold. 
 ρs Ø d CG CL Mn Mw 
 (g·m-2) (%) (nm) (%) (%) (g·mol-1) (g·mol-1) 
PLGA scaffold 2.6 85 617 56 44 45 000 87 000 
Table 1 gathers the surface density, porosity, average fibre diameter, copolymer composition and 
average molar mass of the initial scaffold. As a result of the preliminary characterisation, the 
polyester based (PLGA) scaffold was revealed to accomplish the specifications to be used as a 
model case. 
3.2. In vitro hydrolytic degradation  
The hydrolytic degradation of polyester-based scaffolds under abiotic aqueous environments is 
known to take place through breakage of the ester bonds, exponentially auto-catalysed by the 
presence of carboxylic groups [17]. The microstructural changes occurred in the scaffold induce 
the formation of macroscopic pores or cracks and the loss of monomeric and oligomeric species, 
thus reducing the mass of the polymers and finally decomposing their architecture until 
bioassimilation or excretion [18]. 
The results of the monitoring of the scaffold along the in vitro hydrolytic degradation in ultra-
pure water and PBS are plotted in Figure 3, under the same temporal X-axis in order to compare 
the response given by different techniques. Parameters such as (a) mass, (b) average molar mass 
in number (Mn), (c) temperature of the peak of the endotherm superimposed to the glass transition 
(Tgt-P), (d) pH, (e) conductivity and (f) amount of acid released were chosen for the degradation 
characterisation. A deep explanation is hereinafter given in each subsection in order to get a 
glance of the performance of each key indicator chosen for the analysis. 
3.2.1. Mass-loss 
Mass-loss evolution was measured on the sample-vial assembly by gravimetric analysis, which is 
the most commonly used parameter as indicator of degradation. For the case of PLGA scaffolds, 
the mass-loss profile was similar under both water and PBS media during the first 30 days, as 
shown in Fig. 3a. However, after 30 days, the remaining mass of degraded PLGA scaffolds 
followed different patterns depending on the medium of degradation. Under water, PLGA started 
to disintegrate until completion after ~60 days, with an important slope at its degradation profile. 
In contrast, under PBS, the mass of the scaffold remained almost constant until ~90 days. After 
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that, a drop of mass took place after ~125 days with a similar slope than that shown under water. 
The samples were then completely disintegrated after ~150 days. These results were in 
accordance with those reported for other scaffolds of PLGA where similar degradation extents 
were found [27], [28]. 
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Figure 3. Evolution of hydrolytic degradation indicators for PLGA scaffolds in ultra-pure water and 
phosphate buffer solution (PBS): (a) mass, (b) average molar mass in number (Mn), (c) temperature of the 
peak of the endotherm superimposed to the glass transition (Tgt-P), (d) pH, (e) conductivity and (f) amount 
of acid released. 
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3.2.2. Molar mass  
The in vitro hydrolytic degradation was monitored in terms of molar mass by means of size 
exclusion chromatography (SEC). The average molar mass in number (Mn) was considered as the 
most representative parameter of this analysis, which results are plotted in Fig. 3b. 
As a result of the hydrolytic degradation of the ester bond and the subsequent chain scission, a 
shift of the molar mass towards lower values was expected. Actually, when the PLGA scaffolds 
were submerged into water, a continuous linear fall from initial Mn values ~45·103 g·mol-1 to 
values ~15·103 g·mol-1 up to ~20 days was found. Afterwards, the samples were impossible to 
handle. Under PBS, the decay was monitored up to ~95 days, adapting the profile to an apparent 
exponential decrease function, until Mn values ~5·103 g·mol-1. After that, the specimens were 
entirely collapsed and no more analyses could be carried out. These results were in agreement 
with literature [20], [21], [28]. 
 
Figure 4. Molar mass distributions of PLGA scaffolds exposed to hydrolytic degradation in ultra-pure 
water (left) and PBS (right). 
Deeper insight could be obtained from SEC analyses. Figure 4 shows the molar mass distributions 
of the PLGA scaffolds subjected to ultra-pure water and PBS media. A unimodal distribution was 
observed for non-exposed PLGA, which exhibited a sharp peak at 100 kDa. When exposed to 
ultra-pure water, the molar mass distribution were displaced to lower molar masses, slightly 
increasing their width. A breakage of the ester bonds seemed to take place for long polymer 
chains, producing a broader distribution of chain sizes. After ~20 days of degradation, the peak 
was located around 10 kDa. In contrast, scaffolds immersed in PBS showed a different 
degradation pattern. Until ~30 days, a diminution of the height and a broadening of the peaks 
were observed. The height and shape of the peak was practically maintained from day 30 to day 
50 but displaced towards lower molar masses, suggesting that all polymeric chains were equally 
degraded. The lowest values of molar mass were reached after ~20 and ~95 days in water and 
PBS, respectively. The formation of different segmental‒size populations was suggested, due to 
the appearance of multi-modal curves caused by the particular hydrolysis mechanism [18]. 
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Figure 5. Normalised average molar mass in number (Mn) as a function of the exposure time of PLGA 
scaffolds to ultra-pure water and PBS. Inset: Detail of the stage 1 from immersion to day 30th. Mass loss 
is included as dotted lines. 
The degradation kinetics were studied in Figure 5, where the normalized value of Mn is plotted 
as a function of the degradation time. As commented above, samples subjected to degradation in 
ultra-pure water after 20 days were impossible to handle so that the degradation mechanism was 
mainly studied for the PBS medium. According to the mass-loss evolution (Fig. 3a), two well 
differentiated stages could be observed. In the inset of Fig. 5 the normalized number-average 
molar mass and the mass-loss are plotted as a function of time. A stage 1 was defined between 
day 0 and day 30. The non-linear behaviour of the mass loss perceived in this stage in both media 
suggested an autocatalytic predominant random scission [40]. However, the presumable 
acidification of the medium when immersed in water, may had promoted more autocatalytic 
hydrolysis reactions [17], [18]. Several studies found that a combination of random and end 
scission is the most common mechanism as well as that an autocatalytic process is more often 
expected than non-catalytic hydrolysis [41], [42]. From day 30 onwards, the stage 2 was observed. 
While the samples in water were completely disintegrated, a deceleration of the Mn variation could 
be perceived in the PBS medium, which was indicative of a non-catalytic hydrolysis contribution. 
This lower catalytic behaviour in PBS was due to the capability of PBS to buffer the acidification 
of the media which would be supposed to have occurred due to the released low molecular weight 
acidic species. 
3.2.3. Thermal properties 
The use of differential scanning calorimetry is essential to understand the thermal properties of 
polymers subjected to different degrading conditions [43]–[50]. Indicators of degradation such as 
the cold-crystallization temperature [44], the partial melting areas [45], the crystallinity degree 
[51], the relative partial crystallinity or the balance among amorphous and rigid amorphous 
fractions [52] have been previously proposed for monitoring degradation. 
For PLGA scaffolds, no relevant cold-crystallisation and melting behaviours were observed, 
which ensured that no formation of significant crystalline fractions that could difficult the 
bioassimilation of scaffolds by macrophagues was produced. Figure 6 shows the DSC traces of 
the first heating scan of non-exposed PLGA and those subjected to in vitro hydrothermal 
degradation in both media. The analysis was thus focused on the temperature region from 0 to 
100ºC, where the glass transition and the endothermic enthalpy associated to the release of energy 
accumulated during physical annealing at temperatures below the glass transition are shown. This 
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sharp endotherm was revealed at short degradation times, and became broader the longer the 
hydrolytic exposure was. This phenomenon variated from unimodal to bimodal after 15-20 days, 
which was ascribed to the different glass transitions of the components of the copolymer, i.e. 
poly(glycolide) (PGA), between 35 and 40 ºC, and poly(lactide) (PLA), between 55 and 60 ºC 
[53]. 
The temperatures of the peaks of the endotherm superimposed to the glass-transition (Tgt-P) were 
chosen as indicators of degradation, as plotted in Fig. 3c. The initial Tgt-P values were located 
around 54.5 ºC, which decoupled towards high temperature (high-T) and low temperature peaks 
(low-T). The low-T peak, decreased to ~45 ºC under water and to ~35 ºC under PBS, 
corresponding to a 17% and a 35% of reduction, respectively, with similar fashion as that shown 
by mass-loss. These results are in concordance with other reports that suggested a more 
preferential hydrolytic degradation of the glycolic-glycolic and glycolic-lactic ester linkages, in 
contrast to that of the lactic-lactic bond in random poly(lactide-co-glycolide) polymer chains [54]. 
Thus, the generation of the independent homopolymeric new segments of poly(lactic acid) and 
poly(glycolic acid) would contribute to the appearance of separated glass transition events. 
 
Figure 6. First heating DSC traces for PLGA scaffold after immersion in ultra-pure water and PBS as a 
function of the exposure time. 
3.2.4. Surface morphology 
The surface morphology of the scaffolds subjected to the in vitro hydrolytic degradation 
procedure was assessed by means of field-emission scanning electron microscopy (FE-SEM) as 
a function of the exposure time. Figure 7 shows the surface micrographs of PLGA scaffolds 
submitted to both media after 5, 10 and 15 days of immersion. Afterwards, handling samples was 
not possible. 
In particular, for PLGA scaffolds immersed in water, a general coalescence, and loss of the initial 
nanofibrous arrangement as well as growth of pores was perceived. Fibres swelled and seemed to 
coalesce after 5 days of exposition. After 10 days of immersion, coalescence increased and pores 
seemed to appear in the surface of scaffolds. Finally, after 15 days, the structure completely 
coalesced and the pores continuously grew. This behaviour can be ascribed to the hydrolytic 
degradation behaviour of PLGA, in which water penetrated and diffused into fibres which 
substantially swelled until coalescence. Afterwards, hydrolytic degradation in bulk occurred and 
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pores appeared due to the release of low molar mass compounds to the hydrolytic media [18], 
[55]. These observations were in agreement with the results drawn from experiments of mass-loss 
and DSC shown in Fig. 3, in which the main degradation stage seemed to be triggered around 15 
days. Indeed, the molar mass of PLGA at this stage decreased by 50%, thus supporting the 
statement of threshold of performance in this medium. 
However, when subjected to PBS, the degradation process appeared to be considerably different 
and slower than that observed in water. Although a swelling effect seemed to take place after 5 
days of immersion, conglutination was not reached. After 10 days, swelling hardly occurred and 
some fibres looked to be broken or separated, showing more terminal ends. In addition, tiny holes 
appeared in fibres, indicating individual fibre degradation. After 15 days, similar morphology was 
observed but small pores became higher and deeper, due to the advance of degradation. In contrast 
with the experiments in water, although PLGA also showed a 50% reduction of molar mass at 
this stage and the trigger of degradation was pointed out by DSC, the mass-loss profile followed 
a plateau stage during longer times, due to the inhibition of acidic species by PBS, thus 
decelerating the chain scission of the scaffolds and consequently maintaining the structure. 





















Figure 7. FE-SEM images (3 kV, 1000×, 10µm) of the scaffold surface subjected to degradation in water 
(left) and PBS (right). 
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3.2.5. Analysis of the hydrolytic degradation media 
Though the significance of the characterisation of the scaffolds is essential to understand the 
effects of the degradation on their molecular architecture and thus on their physico-chemical 
properties and performance, the parallel observation of the hydrolytic degrading media can offer 
quick information of the state of degradation and even more, fast data to infer the impact of the 
degradation of biopolymer polyester-based scaffolds. The evolution of the pH, conductivity and 
acid released are shown in Figs. 3d, e and f, respectively.  
When immersed in water, the pH remained constant until day 15, when it dramatically decreased 
from neutral pH ~7 to acidic pH ~3 around day 30, as displayed in Fig. 3d.  This drop was assigned 
to a large release of acidic species, not only glycolic and lactic acid units but also acidic oligomers 
that may cause acidification of the media, according to other studies [18], [21]. In contrast, when 
samples were exposed to PBS, the general tendency of the pH was to remain almost constant 
along the degradation process, due to the ability of this solution to neutralise acidic species 
released during degradation, as previously suggested. Nonetheless a slight diminution can be 
considered from pH 7.4 to pH 6.6 in concordance with results found by other authors [56]–[60], 
coinciding with the main mass-loss stage in Fig. 3a. 
Concerning conductivity, it showed an inversed pattern than that exhibited by pH at similar stages 
(see Fig. 3e). When measured in ultra-pure water, the conductivity remained constant showing 
values around 35 µS·cm-1up to ~20 days. After that, an abrupt growth was observed, reaching 
conductivities near to 500 µS·cm-1 almost symmetrically to the pH evolution. However, the 
intrinsic conductivity of the PBS media showed such a high value that the effect of acidic species 
released to the media was overlapped. Conductivity remained constant around 110 mS·cm-1, 
characteristic of the phosphate buffer solution. 
 
Figure 8. Titration pattern curves for water (circles) and PBS (squares) with lactic (solid) and glycolic 
(open) acids. 
The pH and the release of acid species could be correlated by means of titration patterns, which 
were prepared for lactic and glycolic acids, as shown in Figure 8. Similar titration profiles were 
obtained for both species. A Boltzmann-like trend was observed in water and PBS. By measuring 
the pH of the degradation media and the aid of these curves, the amount of acid released in the 
degradation media as a function of time could be estimated. Thus, in Fig. 3f, a similar but delayed 
acid releasing profile was shown for ultra-pure water and PBS. First, a slow release period was 
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found, followed by a fast release stage. In ultra-pure water, the inflection point was located after 
~30 days. However, in PBS, the slow release period was prolonged until ~70 days, when a fast 
release was found. Still, when the release was faster, it was quicker in water than in PBS, due to 
the autocatalytic hydrolytic reaction taking place in water, as proposed by the degradation kinetics 
studied by SEC. 
3.3. In vitro biocompatibility 
3.3.1. Cell attachment and viability 
The evaluation of the cell capacity to be attached and proliferate onto the scaffolds over time is 
one of the fundamental approaches to take into account when assessing biocompatibility. It is 
known that cells attachment decrease when the scaffolds pore size is increased [61] and similar 
effect could be observed depending on the nanofibrous arrangement. For this purpose, fibroblasts 
were seeded onto the PLGA scaffold and cultured along 48 and 96 h. Then, the cells were nuclear 
stained with DAPI. A great number of cell was observed in both conditions, as shown in Figure 
9a, indicating that PLGA supported cell adhesion. Indeed, scanning electron microscope images 
from scaffolds cultured during 48 h revealed that the cells were completely attached to the scaffold 
and formed a continuous layer, covering the whole surface (Figure 9b). The cell proliferation 
was also measured by MTT assay. As expected, cells were able to grown on the scaffold after 48 
and 96 h. It was observed a slight increase of proliferation over the time, which results are plotted 
in Figure 9c. 
3.3.2. Inflammatory response of cells 
When assessing biocompatibility, the study of whether the scaffold induces an inflammatory 
response on the cells is crucial [33], [62]. Among other methods to evaluate the inflammatory 
response, pyrogenic test is one of the fastest methods, giving as a result quite relevant information. 
In vitro pyrogen test method recommended by the FDA requires the measurement of IL-6 and IL-
1 beta as pro-inflammatory cytokines. In this particular case, we decided to include TNF-a as well 
to make the assay more robust and IL-10 as an indicator of a potential anti-inflammatory effect. 
Peripheral blood mononuclear cells (PBMCs) were cultured onto PLGA scaffolds during 5 h and 
subsequently RNA was extracted for gene expression analysis. Cells were also incubated with 
PHB as positive control, as it is a widely used polymer in regenerative medicine [38], [63]. Cells 
cultured without any scaffold were considered as negative control. IL-1β (interleukin 1β) 
expression was induced after culture with PLGA scaffolds but values were lower than those 
observed with PHB scaffolds. Same results were observed with IL-6 (interleukin 6), IL-10 
(interleukin 10) and TNF (tumor necrosis factor), as observed in Figure 9d. 
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Figure 9. (a) Nuclear staining with DAPI of human fibroblasts cultured on PLGA scaffolds for 48 h (left) 
and overlapping images of DAPI and transmitted light (right). Scale bar 50 µm; (b) Scanning electron 
microscope images of fibroblasts cultured during 48 h in PLGA scaffolds. Scale bars 100 µm (left) and 10 
µm (right); and (c) Fibroblasts viability on PLGA scaffolds measured at 48 h and 96 h by MTT assay. 
Absorbance was measured at 550 nm, data are expressed as arbitrary units; (d) IL-1β, IL-6, IL-10 and 
TNF gene expression of PBMCs incubated with PLGA scaffold, PHB scaffold and without any scaffold 
(control). 
3.3.3. Toxicity of the monomeric constituents of the scaffold 
The hydrolytic degradation of the polyester based scaffolds generates the release of low molar 
mass compounds to the surrounding media of the implant. These compounds, ultimately comprise 
the monomeric constituents of the polymer material [18], [55]. The chemical composition of the 
scaffolds focused on this study is based on the copolymer poly(lactide-co-glycolide) composed 
of lactic and glycolic acid units. Accordingly, the study of the effect of these monomeric 
compounds on the cell viability in terms of the toxic concentration is substantially relevant. The 
MTT results are shown in Figure 10a and 10b. Human fibroblasts and Keratinocytes were 
incubated on different concentrations of lactic and glycolic acids. In both acids, toxicity was found 
at concentrations above 30 mM which was correlated with a decrease of the absorbance measured 
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at 550 nm. Conversely, no toxicity was found at lower concentrations and no differences were 
observed in comparison to the control sample (0 mM). 
 
Figure 10. Toxicity evaluation for different concentrations of lactic (a) and glycolic (b) acids by MTT 
assay. 
3.4. Semi-quantitative comparison of monitoring techniques in terms of promptness of 
identification, simplicity, knowledge and cost 
Two radar-like charts, plotted in Figures 11a and 11b were considered in this study to compare 
the several techniques used for the in vitro validation (hydrolytic degradation and 
biocompatibility, respectively) for a polyester based scaffold. Aspects such as the promptness of 
identification, the simplicity of obtaining results, the depth of offered knowledge, and the cost of 
the techniques need to be taken into account in order to offer a general overview of techniques. 
Accordingly, techniques were inter-compared in terms of the cited aspects and rated based on a 
Likert-scale with a range of 1 to 5, where 1 denoted the lowest desired value and 5 the highest 
desired value for the appropriate evaluation of the technique for every factor of comparison. For 
the sake of clearness, it is important to remark that the square bound by corners represent the most 
convenient value for each variable. Thus, the highest frame square should represent the cheapest, 
simplest and promptest technique, which also provides more knowledge about what is happening 
during the degradation. 
All the techniques and results shown above offer a particular and specific vision of the in vitro 
validation of polyester based scaffolds for biomedical applications, since each method possesses 
some characteristics that differentiate it from others. The appropriate analysis of these 
characteristics would result in a useful picture to set up a suitable plan of analysis for the in vitro 
validation of polyester-based scaffolds depending on the balance between the interest in 
ascertaining the trigger of the process or going deeper into the knowledge of the causes and effects 
along validation. 
O. Gil-Castell, J. D. Badia, I. Ontoria-Oviedo, D. Castellano, B. Marco, A. Rabal, J. J. Bou, A. Serra, L. Monreal, M. 
Blanes, P. Sepúlveda, A. Ribes-Greus. In vitro validation of biomedical polyester-based scaffolds: Poly(lactide-co-
glycolide) as model-case. Polymer Testing 2018;66:256-267 
20 
 
Figure 11. Radar-like chart comparing techniques for the in vitro validation of a polyester based scaffold 
in terms of (a) hydrolytic degradation and (b) biocompatibility according to promptness of identification, 
simplicity, depth of knowledge and favourable cost of the technique. 
A comparison of the response of a set of different materials and/or formulations to an in vitro 
validation procedure can be expensive and highly time-consuming if all the techniques are 
applied. However, a fast trial to choose the right material according to the performance needs may 
be practical considering promptness of identification. The rapidness of identification of 
degradation is essential in preliminary tests. Hydrolytic degradation can be identified after a 
month of exposure for the majority of techniques. However, techniques such as SEC and DSC 
can offer information at shorter times, being the former extremely accurate in measuring 
degradation from the very beginning. Biocompatibility assays give, in general, a fast response in 
comparison to the study of the hydrolytic degradation. The immunofluorescence, MTT, FE-SEM, 
pyrogenic test and MTT toxicity assays bring results in a relative short time-span. 
The estimation of the simplicity of the techniques is relevant when aspects such as the proficiency 
needed to become expert in the technique to prepare samples and experiments, run tests and post-
operate the results appropriately are considered. There are some techniques which are easy and 
simple to use, as the pH or conductivity measurements, the gravimetric analysis and the titration 
for ascertaining the hydrolytic degradation and immunofluorescence to assess biocompatibility, 
where one almost immediately gets the results without exhaustive preparation and post-data 
treatment. However, some other techniques such as FE-SEM, SEC, DSC or MTT assays require 
accurate sample preparation and a thorough procedure to perform the experiment and analyse the 
results. Pyrogenic test is also a highly complex technique in terms of preparation and performance 
of the experiments as well as during the interpretation of results. 
The cost and maintenance of the techniques also plays an important role that needs to be taken 
into account. Some expensive and specific measurements were carried out by FE-SEM, DSC and 
SEC to understand degradation mechanisms. In contrast, ready available techniques used to 
identify and monitor the degradation profile were gravimetric analysis, pH measurement, 
conductometry and titration, which are considered as cheap, simple and easy-to-access 
techniques. In terms of cost, biocompatibility assays showed high variation. The pyrogenic test 
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was the most expensive validation technique for the biocompatibility assessment, followed by the 
FE-SEM analysis, if compared to MTT and immunofluorescence assays. Actually, 
immunofluorescence is an economic technique that should be complemented with other assays. 
MTT and toxicity assays are techniques that offer interesting results at a reasonable cost. 
The depth of knowledge permits distinguishing techniques according to the level, wideness and 
variety of results that can be obtained. In-depth techniques such as SEC and DSC offer results 
from which a great number of suggestions and explanations of the degradation mechanism can be 
obtained, as well as permits infer consequences on the physico-chemical properties. Conversely, 
there are other single-result techniques that offer a macroscopic observation of mass, pH or 
conductivity, which might render information about the occurrence of degradation, but not about 
its state. FE-SEM and titration would be in the middle of the proposed score, since they endow 
useful information suggesting some mechanism of degradation.  Pyrogenic test and MTT assay 
give an overview on how inflammatory and toxic is a polymeric scaffold. Both techniques are 
required when validating the biocompatibility of a given biomedical device. The evaluation of the 
toxicity of the monomeric constituents of the polymer material is also essential to determine the 
maximum tolerable concentration of such compounds when released during the hydrolytic 
degradation. However, although the results obtained from immunofluorescence assay showed that 
cells are actually attached and spread onto the scaffold, this technique do not offer such 
knowledge as the pyrogenic test, the FE-SEM and the MTT assays. 
4. Conclusions 
Monitoring and understanding the in vitro behaviour of polyester-based scaffolds, both 
comprising the study of the hydrolytic degradation and the biocompatibility is essential to ensure 
the desired performance, according to a given biomedical purpose. Poly(lactide-co-glycolide) 
(PLGA) scaffolds were considered as a model-case for polyester-based devices to compare the 
performance of different analytical techniques to monitor the in vitro hydrolytic degradation and 
biocompatibility. 
The suitability of techniques for the in vitro validation procedure was evaluated in terms of the 
promptness of identification, simplicity of obtaining results, depth of offered knowledge, and cost 
and maintenance. Results showed a useful picture to set up an appropriate plan of analysis of the 
degradation of polyester-based scaffolds depending on the balance between the interest in 
ascertaining the trigger of degradation or deep into the knowledge of the causes and effects along 
validation. 
When assessing the hydrolytic degradation, the size exclusion chromatography and the 
differential scanning calorimetry were found to be the techniques that offered deeper knowledge 
and promptness of identification. However, these techniques are costly and complex to evaluate. 
Conversely, economic and simple techniques as the gravimetric analysis of the scaffold and the 
pH and conductivity measurements in the degradation media were considered, which offered little 
knowledge and late identification of the degradation. 
Regarding the biocompatibility evaluation, the pyrogenic test is the most specific that brings more 
knowledge about the cell’s response when seeded into the scaffold. Then, the MTT assay both for 
the scaffold and the monomeric constituents of the polymer was found to be an equilibrated 
technique in terms of the studied parameters. The immunofluorescence test was the simplest and 
the promptest technique at a favourable cost, that brings information about the cell viability and 
distribution onto the scaffold. In order to deeply evaluate the cell morphology and distribution, 
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costly techniques such as FE-SEM are needed. This technique gives an accurate overview of the 
cell morphology and appearance over the scaffold surface. 
These results can be of interest to researchers, technologists and physicians who plan to study the 
balance between performance and degradation of polyester-based scaffolds in a cost-effective 
way, depending on the focus of the test, i.e. from quick discarding trials according to simple 
promptness of identification, to a detailed tailoring of compositions according to the in-depth 
knowledge of the physico-chemical reasons behind the behaviour under physiological conditions. 
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